APstem Therapeutics
An unprecedented era of stem cell therapy has arrived!
An unprecedented era of stem cell therapy has arrived!
APstem Therapeutics is a biotechnology and healthcare startup founded in 2017 with a clear mission to revolutionize medical treatment. The company's groundbreaking discovery of Adult Pluripotent Stem Cells (APSCs™) has paved the way for a new era in stem cell therapy, positioning them as a key player in the fight against challenging diseases and the aging process. In September 2020, APstem Therapeutics secured a notable $2.80M Seed Round investment from a consortium of prominent investors including Beyond Ventures, Oriza Ventures, and Magic Capital. With its headquarters in the United States, APstem Therapeutics is poised to make significant strides in the biotech and healthcare sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $2.80M | 3 |
|
01 Sep 2020 |
| Seed Round | $500.00K | 1 |
|
01 May 2019 |
| Seed Round | $1.00M | 3 |
|
01 Aug 2018 |
No recent news or press coverage available for APstem Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
